The HCV-Dependent Inhibition of Nrf1/ARE-Mediated Gene Expression Favours Viral Morphogenesis
Viruses · 2025
DOI: 10.3390/v17081052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Olga Szostek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Group, Paul-Ehrlich-Institute, 63225 Langen, Germany. Hauptthemen laut MEDLINE: Hepacivirus, Antioxidant Response Elements, Hepatitis C, Nuclear Respiratory Factor 1. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LOEWE DRUID, LOEWE Center DRUID (Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases; Project D2) to EH.
Abstract (Originalsprache)
The life cycle of the hepatitis C virus (HCV) is closely linked to lipid metabolism. Recently, the stress defence transcription factor, nuclear factor erythroid 2 related factor-1 (Nrf1), has been described as a cholesterol sensor that protects the liver from excess cholesterol. Nrf1, like its homologue Nrf2, further responds to oxidative stress by binding with small Maf proteins (sMaf) to the promotor antioxidant response element (ARE). Given these facts, investigating the crosstalk between Nrf1 and HCV was a logical next step. In HCV-replicating cells, we observed reduced levels of Nrf1. Furthermore, activation of Nrf1-dependent target genes is impaired due to sMaf sequestration in replicase complexes. This results in a shortage of sMaf proteins in the nucleus, trapping Nrf1 at the replicase complexes and further limiting its function. Weakened Nrf1 activity contributes to impaired cholesterol removal, which occurs alongside an elevated intracellular cholesterol level and inhibited LXRα promoter activation. Furthermore, inhibition of Nrf1 activity correlated with a kinome profile characteristic of steatosis and enhanced inflammation—factors contributing to HCV pathogenesis. Our results indicate that activation of Nrf1-dependent target genes is impaired in HCV-positive cells. This, in turn, favours viral morphogenesis, as evidenced by enhanced replication and increased production of viral progeny.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Group, Paul-Ehrlich-Institute, 63225 Langen, Germany.
- Digital Health Cluster, Hasso-Plattner-Institute, University of Potsdam, 14482 Potsdam, Germany.
ORCID-Profile: Daniela Bender, Eberhard Hildt
Förderung
- LOEWE DRUID
- LOEWE Center DRUID (Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases; Project D2) to EH
Zitieren
APA
Szostek, O., Schorsch, P., Bender, D., Glitscher, M., & Hildt, E. (2025). The HCV-Dependent Inhibition of Nrf1/ARE-Mediated Gene Expression Favours Viral Morphogenesis. Viruses. https://doi.org/10.3390/v17081052
Vancouver
Szostek O, Schorsch P, Bender D, Glitscher M, Hildt E. The HCV-Dependent Inhibition of Nrf1/ARE-Mediated Gene Expression Favours Viral Morphogenesis. Viruses. 2025. doi:10.3390/v17081052
BibTeX
@article{Szostek2025,
author = {Szostek, Olga and Schorsch, Patrycja and Bender, Daniela and Glitscher, Mirco and Hildt, Eberhard},
title = {The HCV-Dependent Inhibition of Nrf1/ARE-Mediated Gene Expression Favours Viral Morphogenesis},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17081052}
}
EUVIMED